CHELSEY GRAY: Open Payments
NPI 1306157326 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,257 in 54 payments from 14 companies in 2025. Trend: 2023 $1,392 · 2024 $1,765 · 2025 $1,257
Food & beverage: $1,167Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $238 |
| UCB, Inc. | 9 | $174 |
| GENZYME CORPORATION | 2 | $156 |
| Janssen Biotech, Inc. | 5 | $142 |
| Novartis Pharmaceuticals Corporation | 6 | $119 |
| Lilly USA, LLC | 4 | $99 |
| E.R. Squibb & Sons, L.L.C. | 5 | $80 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| Galderma Laboratories, L.P. | 3 | $52 |
| Amgen Inc. | 2 | $39 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, TREMFYA, COSENTYX, Sotyktu, RINVOQ, TALTZ.
Industry payments across NY — which companies pay providers there.
